GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adagio Medical Holdings Inc (NAS:ADGM) » Definitions » Other Gross PPE

ADGM (Adagio Medical Holdings) Other Gross PPE : $3.88 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Adagio Medical Holdings Other Gross PPE?

Adagio Medical Holdings's Other Gross PPE for the quarter that ended in Dec. 2024 was $3.88 Mil.

Adagio Medical Holdings's quarterly Other Gross PPE increased from Mar. 2024 ($2.23 Mil) to Sep. 2024 ($3.42 Mil) and increased from Sep. 2024 ($3.42 Mil) to Dec. 2024 ($3.88 Mil).

Adagio Medical Holdings's annual Other Gross PPE increased from Dec. 2022 ($2.15 Mil) to Dec. 2023 ($2.29 Mil) and increased from Dec. 2023 ($2.29 Mil) to Dec. 2024 ($3.88 Mil).


Adagio Medical Holdings Other Gross PPE Historical Data

The historical data trend for Adagio Medical Holdings's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adagio Medical Holdings Other Gross PPE Chart

Adagio Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Other Gross PPE
0.56 2.15 2.29 3.88

Adagio Medical Holdings Quarterly Data
Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial 0.76 2.29 2.23 3.42 3.88

Adagio Medical Holdings Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Adagio Medical Holdings Business Description

Traded in Other Exchanges
N/A
Address
26051 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.